Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group

No Thumbnail Available

Authors

Monk, Bradley J.
Sill, Michael W.
Hanjani, Parviz
Edwards, Robert
Rotmensch, Jacob
De Geest, Koen
Bonebrake, Albert J.
Walker, Joan L.

Issue Date

2011

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Monk, Bradley J.; Sill, Michael W.; Hanjani, Parviz; Edwards, Robert; Rotmensch, Jacob; De Geest, Koen; Bonebrake, Albert J.; Walker, Joan L. Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group. Gynecologic oncology. 2011, . 120(3):459-463.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/59923

PubMed ID

21144560

DOI

ISSN

0090-8258
1095-6859

EISSN

Collections

Faculty Bibliography Database